MedPath

Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist

Not Applicable
Completed
Conditions
Arthroscopic Surgery
Interventions
Device: Ostenil
Procedure: Standard arthroscopic procedure
Registration Number
NCT01254682
Lead Sponsor
TRB Chemedica AG
Brief Summary

The primary objective of this study is to evaluate the efficacy and safety of Ostenil application (1% hyaluronan) after arthroscopy of the wrist.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Male and female patients between 18 and 80 years of age
  • Minimum pain score of 2 according to modified Mayo Wrist Score
  • Patients in good general health/nutritional condition
  • Signed written informed consent
Exclusion Criteria
  • Alcohol / drug abuse, drug addiction or neurotic personality disorder; patients with mental illness or suicidal tendency
  • Severe intercurrent illness (like uncontrolled diabetes mellitus or thyroid disease, carcinoma,...)
  • Fertile women without medically secured contraception(hysterectomy, sterilization, contraceptives,...)
  • Subjects having a high probability of non compliance to the study procedures according to investigator's judgement (like illiteracy, insufficient German linguistic knowledge)
  • Contraindication for the use of one of the investigational products or for the scheduled anesthesia
  • Concomitant or previous participation in a clinical trial within the last 3 months
  • Intraarticular treatment with a sodium hyaluronate-based product within the last 6 months
  • Intraarticular treatment by the use of corticoid containing substance within the last 3 months
  • Concomitant illness or injury influencing study evaluation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hyaluronic acid sodium salt (1%, 20mg/2ml)Ostenil-
Standard arthroscopic procedureStandard arthroscopic procedure-
Primary Outcome Measures
NameTimeMethod
Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment 3 months after arthroscopic surgery.Baseline and 3 months

Mayo wrist score evaluation consisting of 4 sections:

* Maximal grip strength on injured side (compared to maximal strength of contralateral side, measured by 4-point scale, ranking from '0' for minimal to '30' for maximal strength)

* Range of motion (measured by 4-point scale, ranking from '0' for minimal to '20' for maximal mobility)

* Pain (measured by 4-point scale, ranking from '0' for maximal to '20' for minimal pain)

* Function in daily activities (measured by 4-point scale, ranking from '0' for minimal to '30' for maximal function)

Secondary Outcome Measures
NameTimeMethod
Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment.Measured during the 6-month duration of participation
Disabilities of the arm, shoulder, and hand (DASH) outcome measureMeasured during the 6-month duration of participation
Grip strengthMeasured during the 6-month duration of participation
Visual analogue scale of pain (VAS; 100 mm)Measured during the 6-month duration of participation
Clinical Global Impression (CGI)Measured during the 6-month duration of participation
Inter-group comparison of Mayo wrist subscores in subjects with or without post-arthroscopic hyaluronan treatment.Measured during the 6-month duration of participation

* Maximal grip strength on injured side (compared to contralateral side)

* Range of motion

* Pain

* Function in daily activities

Number of subjects with Adverse Events as a measure of safety and tolerabilityMeasured during the 6-month duration of participation

Trial Locations

Locations (1)

Orthopädische Gemeinschaftspraxis

🇩🇪

Straubing, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath